Clinical Trials
Sunstone is a leader in the delivery of psychedelic-assisted therapy in the medical setting, focusing on the development and execution of clinical trials today and moving towards clinical delivery when therapies are approved.
Get to Know Sunstone
Trials Currently Recruiting
Upcoming Trials
Psilocybin for Palliative Care : A Multicenter, Triple-Blind Phase 2 Randomized Controlled Trial of Psilocybin Therapy for Demoralized Adults Near the End of Life
Closed Trials
Innovation and Iteration of Psychedelic Therapies
Simultaneous Administration and Integration
Participants benefit from sharing their experiences and insights with their cohorts—extending compassion to one another—and often request to maintain connection beyond treatment.
Hands-On and Simulated Training
Sunstone therapists receive hands-on experience with oversight and guidance from some of the most experienced individuals in the field; additionally, therapists are supported by a digital skill-building platform.
Experience Optimization
Trial research data powers the continual development of guidelines and best practices for delivering the highest standards of care and safety.
Purpose-Built Treatment Space
The Bill Richards Center for Healing is the first psychedelic research facility built within a community cancer center that can accommodate both group and individual treatment.